Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data Defines Distinct PGx, Cogenic and Diagnostic Units: Mar 1, 2006 (rev. 2)

NEW YORK, March 1, (GenomeWeb News) - Clinical Data announced today the division of its business into three units.

 

They are PGxHealth, Cogenics, and Vital Diagnostics.

 

The PGX Health division includes assets from newly acquired Genaissance to develop therapeutic diagnostics. The unit is developing CNS, cardiovascular, and oncology tests, the company said in a statement.

 

The Cogenics unit, which represents the combined operations and marketing infrastructure of Genaissance, Lark and Icoria to provide comprehensive pharmacogenomics and molecular services, is developing GLP-validated and research assays.

 

Vital Diagnostics, derived from the operations of Clinical Data, Vital, and Electa Labs, is geared toward IVD services for customers in 100 countries.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.